|
Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts Clinical research trials and Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts. Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts clinical trial. Participants frequently get the best healthcare available for their Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts  Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts
Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts
For Condition: CD4 Lymphocytopenia,Idiopathic CD4 Positive T Lymphocytopenia
Status: Completed
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: This study will evaluate HIV-negative patients with unusually low levels of CD4+ T lymphocytes (a type of white blood cell) to learn more about the clinical symptoms, cause, immunology, and biology of this problem. CD4+ T lymphocytes play an important role in immune function, and low counts may leave people susceptible to unusual infections. CD4+ T cell deficiencies are most often associated with HIV infection. Patients 8 years of age and older with CD4+ T cell counts below 300 cells/mm3 who test negative for HIV infection by standard blood tests may be eligible for this study. Patients' family members and partners may also be enrolled to investigate the possible role of a genetic factor or exposure to some agent in this problem. Patients will be evaluated at the NIH Clinical Center at least once, and generally two or more times. The evaluations, which may be done on an inpatient or outpatient basis, will include some or all of the following tests and procedures: - Complete physical examination. - Medical history, including questions about sexual contacts, intravenous drug use, travel, blood transfusions, previous illnesses, including sexually transmitted diseases, and health of family members. - Urine test. - Blood tests for routine and research purposes, including tests for HIV, hepatitis, syphilis and other infections, evaluation of immune function, and culture for viruses in the HIV family. No more than 1 pint of blood will be drawn every 6 weeks. - Pregnancy test for women of childbearing potential. - Skin tests for tuberculosis and immune function. These tests involve injecting a small amount of the substance to be tested just under the skin and looking for a raised area 1 to 2 days later. - Apheresis. Whole blood is collected through an arm vein (similar to donating blood), and circulated through a cell separator machine, where it is spun to separate the components. The red cells are then returned to the patient either through the same needle or through a needle in the other arm, and the plasma and white cells are extracted for study. The procedure, which takes 1 to 2 hours, may be repeated up to 3 times. Family members will have 60 cc (4 tablespoons) of blood drawn to determine CD4+ T cell counts.
Details: Low CD4+ T-cells in the absence of known etiology has been called idiopathic CD4+ T lymphocytopenia, and a case definition was established by the CDC as a CD4 count less than 300 cells/mL on 2 consecutive samples in a patient uninfected by HIV and with no other disease or treatment that might provide a reasonable alternative explanation for CD4 lymphocytopenia. Early investigations centered on a search for a novel retrovirus, but we and others have not found evidence of such a retrovirus. The patients that we have seen are heterogeneous, and it appears likely that there will be multiple etiologies for this syndrome. We are currently continuing to follow subjects long term and to see new subjects in order to continue to characterize the clinical aspects of patients who meet the case definition; to determine the natural history of ICL, and to provide samples to researchers who are interested in investigations into the pathogenesis of ICL.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA Adults greater than or equal to 18 years of age. CD4 count less than 300 cells/mmL on 2 consecutive samples. Uninfected by HIV as determined by ELISA with confirmatory Western Blot Absence of disease or treatment that might provide a reasonable alternative explanation for the CD4 cell count or might confound the evaluation. Examples of such diseases would be any acute, severe medical illness that had not resolved when CD4 cell counts were obtained; active tuberculosis; leukemia or lymphoma; or previously characterized immunodeficiency disorder. Treatment that that might provide a reasonable alternative explanation includes chemotherapy over a field that could affect bone marrow or supraphysiologic glucocorticoid therapy. Capable of providing informed consent.
Total Enrollment: 100
Location and Contact Information:
National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 920256; 92-I-0256
Study Start Date: September 1, 1992
Record last reviewed: July 8, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001319
Other Cd4 Lymphocytopenia Studies:
1. Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts
Related Studies:
Other CD4 Lymphocytopenia Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluation of HIV-Negative Patients with Low CD4+ T Lymphocyte Counts
|
|
|
|
|
|
|
|
